Form D · Biotechnology
MOST Cardio LLC
Salem, MA · CIK 0001716930
Offering snapshot reported Sep 13, 2017 · SEC filing
- Reported sold
- $600K Offering amount: $5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 23, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 13, 2017 | Initial | $600,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-294615
Source: Form D, filed Sep 13, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Henri De Guillebon | Director |
| Pavel Menn | Executive |
| Robert Menn | Director |
| Alec Stern | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
121 Loring Avenue Suite 410
Salem, MA, 01970
Salem, MA, 01970